Results 81 to 90 of about 13,389 (206)
Emerging Infectious Diseases, 2007 Melioidosis is endemic in southern and Southeast Asia and northern Australia. Although relatively few indigenous cases are recognized in the Indian subcontinent, a substantial proportion of cases imported into the United Kingdom originate there, probably reflecting patterns of immigration and travel, and underdiagnosis within the Indian subcontinent.
Brent, A +4 more
openaire +3 more sources
RUDN Journal of Medicine, 2018 Melioidosis is a particularly dangerous infection caused by Burkholderia pseudomallei , against which a vaccine has not yet been created. In this regard, the development of effective treatment regimens and emergency prevention of melioidosis is very ...
I A Khabarova +5 more
doaj +1 more source
Saudi Journal of Kidney Diseases and Transplantation, 2020 Melioidosis is an emerging infectious disease in many countries including Bangladesh. Patients with diabetes mellitus are at increased risk for infection by Burkholderia pseudomallei, the causative agent for melioidosis.
Muhammad Abdur Rahim +3 more
doaj +1 more source
A Coinfection Model of Leptospirosis and Melioidosis With Optimal Control
Journal of Applied Mathematics, Volume 2025, Issue 1, 2025.Leptospirosis and melioidosis are emerging tropical diseases that are seriously affecting both human and animal populations worldwide. The actual incidence and fatal cases of the diseases are underreported due to a lack of awareness of the diseases, underuse of clinical microbiology laboratories test, and limitations of the model.
Habtamu Ayalew Engida +5 more
wiley +1 more source
Expert Review of Vaccines, 2002 Melioidosis is a disease caused by the facultative intracellular pathogen Burkholderia pseudomallei iand is associated with a high mortality rate. Melioidosis is endemic in the tropics of southeast Asia and northern Australia and is of worldwide concern, particularly as it is a potential agent of bioterrorism or biological warfare.
Jonathan, Warawa, Donald E, Woods
openaire +2 more sources
Melioidosis: Clinical impact and public health threat in the tropics.
PLoS Neglected Tropical Diseases, 2017 This review briefly summarizes the geographical distribution and clinical impact of melioidosis, especially in the tropics. Burkholderia pseudomallei (a gram-negative bacterium) is the major causative agent for melioidosis, which is prevalent in ...
Ramar Perumal Samy +3 more
doaj +1 more source
Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione. [PDF]
, 2016 The major risk factor for melioidosis, an infectious disease caused by B. pseudomallei, is diabetes mellitus. More than half of diabetic melioidosis patients in Thailand were prescribed glibenclamide.
Ato, Manabu +5 more
core +1 more source
Journal of Tropical Medicine, Volume 2025, Issue 1, 2025.Background: Even in well‐resourced settings, the case‐fatality rate of melioidosis approaches 10%. This has prompted an interest in identifying adjunctive therapies that might improve survival. A prospective, multicentre study in Thailand suggested that statin therapy may reduce the incidence of pneumonia in patients with melioidosis; however, the ...
Laura Prideaux +5 more
wiley +1 more source
Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing [PDF]
, 2012 BACKGROUND: Burkholderia (B.) pseudomallei and B. mallei are genetically closely related species. B. pseudomallei causes melioidosis in humans and animals, whereas B. mallei is the causative agent of glanders in equines and rarely also in humans.
Axel Karger +10 more
core +1 more source
Melioidosis in Asia‐Pacific Nations: Expanding Boundaries but Unknowns Remain
Respirology, Volume 30, Issue 10, Page 917-919, October 2025.
Bart J. Currie, Ella M. Meumann
wiley +1 more source